Author:
Hodgson Anjelica,Pakbaz Sara,Mete Ozgur
Publisher
Springer International Publishing
Reference17 articles.
1. Barontini, M., & Dahia, P. L. (2010). VHL disease. Best Practice and Research: Clinical Endocrinology and Metabolism, 24, 401–413.
2. Cassol, C., & Mete, O. (2015). Endocrine manifestations of von Hippel-Lindau disease. Archives of Pathology and Laboratory Medicine., 139, 263–268.
3. Duan, K., & Mete, O. (2017). Hereditary endocrine tumor syndromes: The clinical and predictive role of molecular histopathology. AJSP: Reviews & Reports, 22, 246–268.
4. Favier, J., Méatchi, T., Robidel, E., Badoual, C., Sibony, M., Nguyen, A. T., Gimenez-Roqueplo, A., & Burnichon, N. (2019). Carbonic anhydrase 9 immunohistochemistry as a tool to predict or validate germline and somatic VHL mutations in pheochromocytoma and paraganglioma—A retrospective and prospective study. Modern Pathology, 1–8.
5. Gucer, H., Szentgyorgyi, E., Ezzat, S., Asa, S. L., Mete, O. (2013). Inhibin-expressing clear cell neuroendocrine tumor of the ampulla: an unusual presentation of von Hippel-Lindau disease. Virchows Arch, 463, 593–597.